Amneal Pharmaceuticals, Inc. AMRX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s restricted cash?
- Amneal Pharmaceuticals, Inc. (AMRX) reported restricted cash of $4.17M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s restricted cash changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s restricted cash decreased by 36.6% year-over-year, from $6.58M to $4.17M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s restricted cash has grown at a 38.1% compound annual growth rate (CAGR), from $5.74M to $28.84M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.